Strains of these bacteria have also been linked to weight loss, though we need clinical trials to develop recommendations for probiotics and weight loss
Clinical data show that discontinuing GLP-1 therapy has been associated with weight regain in many participants
May your starting dose stay smooth, your titration stay steady, and your results stay lasting.
doi: 10.1111/dom.13160 Summary Keywords Glucagon-like peptide-1 receptor agonist, intolerance, gastrointestinal adverse effects, network meta-analysis, Dulaglutide, Liraglutide, Semaglutide Citation Zhang Z, Zhang Q, Tan Y, Chen Y, Zhou X, Liu S and Yu J (2023) GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis
Final Thoughts on Retatrutide vs Semaglutide and Tirzepatide Retatrutide is not a GLP-3 drug